Description

Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms. The global metabolomics market is poised to grow by US$ 12.1 billion during 2022-2028, progressing at a CAGR of 11.8% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for metabolomics. The global metabolomics market is segmented on the basis of product, indication, application, and region. By product, the global metabolomics market has been segmented into assays, bioinformatics, detection techniques, separation techniques. The separation techniques segment was the largest contributor to the global metabolomics market in 2021. Based upon indication, the global metabolomics market is categorized into cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, others. According to the research, the cancer segment had the largest share in the global metabolomics market. On the basis of application, the global metabolomics market has been segmented into biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, others. The biomarker discovery segment held the largest revenue share in 2021. Geographically, the global metabolomics market is segmented into Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. Globally, North America made up the largest share of the metabolomics market.

The separation techniques market is further segmented into capillary electrophoresis, gas chromatography, and liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography). The liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography) segment is estimated to account for the largest share of the global metabolomics market. Furthermore, the detection techniques market has been categorized into mass spectrometry, multivariate analysis, and spectroscopy (NMR and FTIR). The mass spectrometry segment held the largest share of the global metabolomics market in 2021 and is anticipated to hold its share during the forecast period.

The global metabolomics market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the metabolomics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: assays, bioinformatics, detection techniques, separation techniques
Indication: cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, others
Application: biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, others
Region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global metabolomics market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Metabolomics market overview
Part 3. Market breakdown by product
– Assays
– Bioinformatics
– Detection techniques
– Separation techniques
Part 4. Market breakdown by indication
– Cancer
– Cardiovascular disorders
– Inborn errors of metabolism
– Neurological disorders
– Others
Part 5. Market breakdown by application
– Biomarker discovery
– Drug discovery
– Functional genomics
– Nutrigenomics
– Toxicology testing
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
Part 7. Key companies
– Agilent Technologies Inc.
– Bio-Rad Laboratories Inc.
– Bruker Corporation
– Danaher Corporation
– LECO Corporation
– Metabolon Inc.
– Shimadzu Corporation
– Thermo Fisher Scientific Inc.
– Waters Corporation
About StrategyHelix
Disclaimer